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Abstract
The Cas9 protein from the Streptococcus pyogenes CRISPR-Cas immune system has been
adapted for both RNA-guided genome editing and gene regulation in a variety of organisms, but
can mediate only a single activity at a time within any given cell. Here we characterize a set of
fully orthogonal Cas9 proteins and demonstrate their ability to mediate simultaneous and
independently targeted gene regulation and editing in bacteria and in human cells. We find that
Cas9 orthologs display consistent patterns in their recognition of target sequences and identify a
highly targetable protein from Neisseria meningitidis. Our results provide a basal set of orthogonal
RNA-guided proteins for controlling biological systems and establish a general methodology for
characterizing additional proteins and adapting them to eukaryotic cells.
Introduction
Clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated
(Cas) systems provide bacteria and archaea with acquired immunity by incorporating
fragments of viral or plasmid DNA into CRISPR loci and utilizing the transcribed crRNAs
to guide the degradation of homologous sequences1, 2. In type II CRISPR systems, a ternary
complex of Cas9 nuclease with crRNA and tracrRNA (trans-activating crRNA) binds to and
cleaves dsDNA protospacer sequences that match the crRNA spacer and also contain a short
protospacer-adjacent motif (PAM)3, 4. Fusing the crRNA and tracrRNA produces a single
guide RNA (sgRNA) that is sufficient to target Cas94.
As an RNA-guided nuclease and nickase, Cas9 has been adapted for targeted gene editing5–9
and selection10 in a variety of organisms. While these successes are arguably transformative,
nuclease-null Cas9 variants may prove to be at least as useful for regulatory purposes, as the
ability to localize proteins and RNA to nearly any set of dsDNA sequences affords
5Correspondence should be addressed to: gchurch@genetics.med.harvard.edu.
4These authors contributed equally to this work.
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ttremendous versatility for controlling biological systems11–17. Beginning with targeted gene
repression through promoter and 5′ -UTR obstruction in bacteria18, Cas9-mediated
regulation was recently extended to transcriptional activation by means of VP64 recruitment
in human cells19, 20. Looking forward, we anticipate a cornucopia of Cas9-mediated
transcriptional activators, repressors, fluorescent protein labels, chromosome tethers, and
numerous other tools.
While the Cas9 protein from S. pyogenes can mediate one activity at many different target
sites, it cannot concurrently mediate a different activity at other targets. For example, a cell
engineered with a Cas9 activator cannot undergo genome editing using a Cas9 nuclease
without also cutting the sites being targeted by the activator. Simultaneously employing
multiple RNA-guided activities within a single cell will require methods of independently
targeting each activity to its own set of target sites. To establish this level of concerted
control over cellular behavior21, 22, we developed methods enabling the characterization of
orthogonal Cas9 proteins for multiplexed RNA-guided transcriptional activation, repression,
and gene editing.
Results
Selecting putatively orthogonal Cas9 proteins
Cas9 RNA binding and sgRNA specificity is primarily determined by the ~36 base pair
repeat sequence in pre-crRNA. We began by examining known Cas9 genes for highly
divergent repeats in their adjacent CRISPR loci. We chose the well-studied Cas9 protein
from Streptococcus pyogenes (SP), the smaller Cas9 proteins from Streptococcus
thermophilus CRISPR1 and Neisseria meningitidis (ST1 and NM), and the large Cas9
protein from Treponema denticola (TD). The CRISPR loci associated with these genes
harbor repeats that differ by at least 13 nucleotides from one another (Fig. 1a).
PAM characterization
Known Cas9 proteins will only target dsDNA sequences flanked by a 3′  PAM sequence
specific to the Cas9 of interest. Of the four Cas9 variants, only SP has an experimentally
characterized PAM, while the ST1 PAM and, very recently, the NM PAM were deduced
bioinformatically. SP is thought to be the most readily targetable due to its short PAM of
NGG10, while ST1 and NM targeting are constrained by PAMs of NNAGAAW and
NNNNGATT, respectively23, 24. We hypothesized that bioinformatic approaches might
infer more stringent PAM requirements for Cas9 activity than are empirically necessary for
effector cleavage due to the additional requirement for spacer acquisition in natural systems.
Because the PAM sequence is the most frequent target of mutation in escape phages, greater
stringency during spacer acquisition might provide redundancy and sometimes preclude
resistance. We therefore adopted a library-based approach to comprehensively characterize
these sequences in bacteria using high-throughput sequencing.
Genes encoding ST1, NM, and TD were assembled from synthetic fragments and cloned
into bacterial expression plasmids with their associated tracrRNAs (Fig. 1b, Supplementary
Fig. 1). Prior experience with variably effective spacer sequences using SP (data not shown)
led us to select two SP-functional spacers for incorporation into the six targeting plasmids.
Each targeting plasmid encodes a constitutively expressed crRNA in which one of the two
spacers is followed by the 36 base-pair repeat sequence specific to a Cas9 protein (Fig. 1b).
Plasmid libraries containing one of the two protospacers followed by all possible 8 base pair
PAM sequences were generated by PCR and assembly25. Future experiments could utilize
>8 base pair libraries to account for even longer PAMs. Each library was electroporated into
E. coli cells harboring Cas9 expression and targeting plasmids, for a total of 12
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tcombinations of Cas9 protein, spacer, and protospacer (Fig. 1c). Surviving library plasmids
were selectively amplified by barcoded PCR and sequenced by MiSeq to distinguish
between functional PAM sequences, which are depleted only when the spacer and
protospacer match (Fig. 1d–e), from nonfunctional PAMs, which are never depleted (Fig.
1f).
To graphically depict the importance of each nucleotide at every position, we plotted the log
relative frequency of each base for matched spacer-protospacer pairs relative to the
corresponding mismatched case (Fig. 2). As hypothesized, our results revealed that NM and
ST1 recognize PAMs that are less stringent and more complex than earlier bioinformatic
predictions, suggesting that requirements for spacer acquisition are indeed more stringent
than those for effector cleavage. Most strikingly, NM absolutely requires a single G
nucleotide positioned five bases from the 3′  end of the protospacer (Fig. 2a), while ST1 and
TD each require at least three specific bases (Fig. 2b–c). Sorting our results by position
allowed us to quantify depletion of any PAM sequence from each protospacer library (Fig.
2d–f). All three enzymes cleaved protospacer B more effectively than protospacer A when
paired with most PAMs, with ST1 exhibiting the greatest preference (Supplementary Fig.
2a). However, there was also considerable PAM-dependent variation in this interaction. For
example, NM cleaved protospacers A and B approximately equally when they were
followed by sequences matching TNNNGNNN, but was 10-fold more active in cleaving
protospacer B for the set of sequences with PAMs matching ANNNGNNN (Supplementary
Fig. 2b).
Our results highlight the difficulty of defining a single acceptable PAM for a given Cas9.
Not only did activity levels depend upon the sequence of the protospacer, but specific
combinations of unfavorable PAM bases substantially reduced activity even when the
primary base requirements were met. We initially identified PAMs as patterns that
underwent >100-fold average depletion with the lower-activity protospacer A and >50-fold
depletion of all derivative sequences in which one base unspecified in the parent (e.g. N) is
set to A, T, C, or G. (Table 1). While these levels are presumably sufficient to defend
against targets in bacteria, we noticed that particular combinations of deleterious mutations
dramatically reduced activity. For example, NM depleted sequences matching NCCAGGTN
by only 4-fold (PAM matches underlined, Supplementary Fig. 2c). We therefore defined a
more stringent threshold requiring >500-fold depletion of matching sequences and >200-
fold depletion of one-base derivatives for applications requiring higher affinity (Table 1).
Orthogonality in bacteria
We originally selected our set of Cas9 proteins for their disparate crRNA repeat sequences.
To verify that they are indeed orthogonal, we cotransformed each Cas9 expression plasmid
with each of the four targeting plasmids containing spacer B. These cells were challenged by
transformation with substrate plasmids containing either protospacer A or protospacer B and
a suitable PAM. We observed plasmid depletion exclusively when each Cas9 was paired
with its own crRNA, demonstrating that all four constructs are completely orthogonal in
bacteria (Fig. 3).
Transcriptional regulation in bacteria
A nuclease-null variant of SP has been demonstrated to repress targeted genes in bacteria
with an efficacy dependent upon the position of the targeted protospacer18, 20, 26. Because
the diverse PAMs of the new variants allow them to target sites lacking the SP PAM, we
wondered whether nuclease-null versions of these proteins might be similarly capable of
targeted repression. We identified the catalytic residues of the RuvC and HNH nuclease
domains of each ortholog by sequence homology and inactivated them to generate nuclease-
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tnull NM, ST1, and TD (Online Methods). To create suitable reporters, we inserted
protospacer B with an appropriate PAM for each Cas9 into the non-template strand within
the coding sequence of a YFP reporter plasmid (Fig. 4a). We cotransformed each of these
constructs into E. coli together with their corresponding targeting plasmids and measured the
resulting fluorescence. Cells with matching spacer and protospacer exhibited much weaker
fluorescence than the corresponding mismatched case for nuclease-null SP, ST1, and
especially NM, but less so for TD. To determine whether this was an artifact of the low
basal activity of the TD reporter, we also tested an alternative reporter design in which
protospacer A was placed in the 5′  UTR, which confirmed that TD is much less effective as
a repressor (Fig. 4b). These results indicate that not all Cas9 proteins are equally suitable for
every task and suggest possible differences between larger Cas9 proteins such as TD and
smaller members of the family. More practically, our results demonstrate that three of our
four orthologs can function as robust RNA-guided repressors in bacteria.
Simultaneous gene regulation and nuclease activity
Having demonstrated that our orthogonal Cas9 proteins are capable of both nuclease activity
and transcriptional repression, we next engineered E. coli to employ both activities
simultaneously. We constructed a plasmid encoding SP to defend against filamentous phage
infection and utilized our previous constructs encoding nuclease-null NM, the most readily
targetable of the orthologs, to repress the YFP reporter. As expected, the resulting cells
successfully repressed YFP transcription and cleaved incoming filamentous phage genomes
at multiple locations within gene III, completely preventing plaque formation by M13mp18
(Fig. 4c) and precluding transformation with a plasmid containing the targeted gene (Fig.
4d). These results demonstrate the ability of our orthogonal Cas9 proteins to mediate
multiple independent activities within a single cell.
Genome editing in human cells
We next sought to apply these Cas9 variants to engineer human cells. We constructed single
guide RNAs (sgRNAs) from the corresponding crRNAs and tracrRNAs for NM and ST1,
the two smaller and predictably active Cas9 orthologs, by examining complementary regions
between crRNA and tracrRNA27 (Supplementary Fig. 2) and fusing the two sequences via a
stem-loop at various fusion junctions analogous to those of the sgRNAs created for SP
(Supplementary Fig. 3). When the existing sequence might cause problems for our
expression system (e.g. due to multiple successive uracils causing Pol III termination), we
generated multiple single-base mutants. The complete 3′  tracrRNA sequence was always
included, as truncations are known to be detrimental8.
All sgRNAs were assayed for activity along with their corresponding Cas9 protein using our
previously described homologous recombination assay in 293 cells8. Briefly, a genomically
integrated non-fluorescent GFP reporter line was constructed for each Cas9 protein in which
the GFP coding sequence was interrupted by an insert encoding a stop codon and
protospacer sequence with functional PAM. Reporter lines were transfected with expression
vectors encoding a Cas9 protein and corresponding sgRNA along with a repair donor
capable of restoring fluorescence upon nuclease-induced homologous recombination (Fig.
5a). Notably, we observed that full-length crRNA-tracrRNA fusions were active in all
instances and therefore represent a reliable method of testing novel Cas9 ortholog activity in
eukaryotic cells (Supplementary Figs. 3–5). Some but not all truncated versions are equally
active. We selected highly active sgRNA for both NM and ST1 to use in future experiments
(Supplementary Figs. 3–5).
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To verify that none of the three proteins can be guided by the sgRNAs of the others in
human cells, we employed the same homologous recombination assay to measure the
comparative efficiency of SP, NM, and ST1 in combination with each of the three sgRNAs.
Importantly, NM and ST1 induced genome editing at levels comparable to SP (Fig. 5b).
Corroborating our findings with crRNAs in bacteria, our results unequivocally show that all
three Cas9 proteins are fully orthogonal to one another, demonstrating that they are capable
of targeting distinct and non-overlapping sets of sequences within the same cell (Fig. 5b,
Supplementary Fig. 6).
To disentangle the comparative contributions of sgRNA and PAM to orthogonal targeting,
we tested a variety of downstream PAM sequences with SP and ST1 and their respective
sgRNAs. Certain PAMs were acceptable to both SP and ST1, enabling both enzymes to
target the exact same sequence, but cutting occurred only when each enzyme was paired
with its corresponding sgRNA. These results highlight the importance of both sgRNA and
PAM for Cas9 activity, but also emphasize that the specific affinity of each Cas9 for its
corresponding sgRNA is sufficient for orthogonality (Supplementary Fig. 7).
Transcriptional activation in human cells
We next investigated the ability of NM and ST1 to mediate transcriptional activation in
human cells. Nuclease-null NM and ST1 genes were fused to the VP64 activator domain at
their C-termini to yield putative RNA-guided activators modeled after our SP activator19.
Reporter constructs for activation consisted of a protospacer with an appropriate PAM
inserted upstream of the tdTomato coding region. Vectors expressing an RNA-guided
transcriptional activator, an sgRNA, and an appropriate reporter were cotransfected and the
extent of transcriptional activation measured by FACS (Fig. 6). In each case, we observed
robust transcriptional activation by all three Cas9 variants, similar to a corresponding TAL-
VP64 activator (Fig. 6). Each Cas9 activator also stimulated transcription only when paired
with its corresponding sgRNA, confirming orthogonal genome regulation by the three Cas9
proteins.
Discussion
By experimentally characterizing and demonstrating orthogonality between multiple Cas9
proteins in bacteria and human cells, we have substantially expanded the repertoire of
orthogonal RNA-guided DNA-binding elements and constructed a pipeline for
characterizing additional examples. Together, these proteins constitute the basics of a
platform enabling simultaneous transcriptional regulation, labeling, and gene editing within
individual cells.
Our results illustrate the remarkable diversity of proteins within a single family of CRISPR
systems. Though clearly related, the Cas9 proteins from S. pyogenes, N. meningitidis, S.
thermophilus, and T. denticola range from 3.25 to 4.6 kb in length and recognize completely
different PAM sequences. These findings are in keeping with the strongly diversifying
selective pressures facing defense systems engaged in molecular arms races28 and suggest
that many other Cas9 proteins may be equally orthogonal.
Using two distinct protospacers for comprehensive PAM characterization allowed us a
glimpse of the complexities governing protospacer and PAM recognition. Differential
protospacer cleavage efficiencies exhibited a consistent trend across diverse Cas9 proteins,
although the magnitude of the disparity varied considerably between orthologs. This pattern
suggests that sequence-dependent differences in D-loop formation or stabilization determine
the basal targeting efficiency for each protospacer, but that additional Cas9 or repeat-
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tdependent factors also play a role. Similarly, numerous factors preclude efforts to describe
PAM recognition with a single sequence motif. Individual bases adjacent to the primary
PAM recognition determinants can combine to dramatically decrease overall affinity.
Indeed, certain PAMs appear to interact nonlinearly with the spacer or protospacer to
determine the overall activity. Moreover, different affinity levels may be required for
distinct activities across disparate cell types. Finally, we observed that our experimentally
identified PAMs required fewer bases than those inferred from bioinformatic analyses,
suggesting that spacer acquisition requirements differ from those for effector cleavage.
This difference is most notable for the Cas9 protein from Neisseria meningitidis, which has
fewer PAM requirements when paired with our spacers than either its bioinformatic
prediction or the currently popular Cas9 from S. pyogenes, and considerably fewer than
either ST1 or TD. It would be interesting to determine whether the total protospacer+PAM
specificity of these four proteins is related to organismal genome size, a relationship that
could point towards more specific Cas9 orthologs. More immediately, the characterization
of NM considerably expands the number of sequences that can be readily targeted with a
Cas9 protein. At 3.25 kbp in length, the NM gene is also 850 bp smaller than the SP gene;
both the NM and ST1 genes are small enough to fit into standard viral vectors for in vivo
delivery. NM may represent a more suitable starting point for directed evolution efforts
designed to alter PAM recognition or specificity. We expect future experiments aimed at
characterizing additional Cas9 orthologs to further improve our mechanistic understanding
and expand our engineering capabilities.
Online Methods
Vector and Strain Construction
Cas9 sequences from S. thermophilus, N. meningitidis, and T. denticola were obtained from
NCBI and human codon optimized using JCAT (www.jcat.de)29 and modified to facilitate
DNA synthesis and expression in E. coli. 500 bp gBlocks (Integrated DNA Technologies)
were joined by hierarchical overlap PCR and isothermal assembly25. The resulting full-
length products were subcloned into bacterial and human expression vectors. Nuclease-null
Cas9 cassettes (NM: D16A D587A H588A N611A, SP: D10A D839A H840A N863A, ST1:
D9A D598A H599A N622A, TD: D13A D878A H879A N902A) were constructed from
these templates by standard methods.
Bacterial plasmids
Cas9 was expressed in bacteria from a cloDF13-aadA plasmid backbone using the medium-
strength proC constitutive promoter. All tracrRNA cassettes, including promoters and
terminators from the native bacterial loci, were synthesized as gBlocks and inserted
downstream of the Cas9 coding sequence for each vector for robust tracrRNA production.
When the tracrRNA cassette was expected to additionally contain a promoter in the opposite
orientation, the lambda t1 terminator was inserted to prevent interference with cas9
transcription. Bacterial targeting plasmids were based on a p15A-cat backbone with the
strong J23100 promoter followed by one of two 20 base pair spacer sequences (Fig. 2D)
previously determined to function using SP. Substrate plasmids for orthogonality testing in
bacteria were identical to library plasmids (see below) but with the following PAMs:
GAAGGGTT (NM), GGGAGGTT (SP), GAAGAATT (ST1), AAAAAGGG (TD). Spacer
sequences were immediately followed by one of the three 36 base pair repeat sequences
depicted in Fig. 1A. YFP reporter vectors were based on a pSC101-kan backbone with the
pR promoter driving GFP and the T7 g10 RBS preceding the EYFP coding sequence. Two
types were created: one with protospacer B + PAM inserted into the non-template strand just
after the start codon of YFP, and one with protospacer A + PAM inserted into the non-
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ttemplate strand in the 5′ -UTR. PAMs are as listed in Fig. 4A and 4B. The plasmid
conferring immunity to filamentous phages via SP features a colE1-erm backbone, the SP
cas9 gene and tracrRNA exactly as in the standard cloDF13-aadA plasmids, and the J23100
promoter driving a CRISPR locus targeting five sites within M13 gene III. Transformed
plasmids carry the bla gene for carbenicillin resistance and either wild-type gene III or a
recoded gene III. The CRISPR locus and recoded gene III were synthesized by Genewiz. All
vectors and sequences are available through Addgene.
Mammalian vectors
Mammalian Cas9 expression vectors were based on pcDNA3.3-TOPO with C-terminal
SV40 NLSs. sgRNAs for each Cas9 were designed by aligning crRNA repeats with
tracrRNAs and fusing the 5′  crRNA repeat to the 3′  tracrRNA so as to leave a stable stem
for Cas9 interaction27. sgRNA expression constructs were generated by cloning the U6-
sgRNA expressing fragments synthesized as gBlocks into the pCR-BluntII-TOPO vector
backbone. Spacers were identical to those used in previous work8. Lentivectors for the
broken-GFP HR reporter assay were modified from those previously described to include
appropriate PAM sequences for each Cas9 and used to establish the stable GFP reporter
lines.
RNA-guided transcriptional activators consisted of nuclease-null Cas9 proteins fused to the
VP64 activator and corresponding reporter constucts bearing a tdTomato driven by a
minimal promoter were constructed as previously described20. All vectors and sequences are
available through Addgene.
Library construction and transformation
Protospacer libraries were constructed by amplifying the pZE21 vector (ExpressSys,
Ruelzheim, Germany) using primers (IDT, Coralville, IA) encoding one of the two
protospacer sequences followed by 8 random bases and assembled by standard isothermal
methods25. Library assemblies were initially transformed into NEBTurbo cells (New
England Biolabs, Ipswich MA), yielding >1E8 clones per library according to dilution
plating, and purified by Midiprep (Qiagen, Carlsbad CA). Electrocompetent NEBTurbo cells
containing a Cas9 expression plasmid (DS-NMcas, DS-ST1cas, or DS-TDcas) and a
targeting plasmid (PM-NM!sp1, PM-NM!sp2, PM-ST1!sp1, PM-ST1!sp2, PM-TD!sp1, or
PM-TD!sp2) were transformed with 200 ng of each library and recovered for 2 hours at 37C
prior to dilution with media containing spectinomycin (50 μ g/mL), chloramphenicol (30 μ g/
mL), and kanamycin (50 μ g/mL). Serial dilutions were plated to estimate post-
transformation library size. All libraries exceeded ~1E7 clones, indicative of complete
coverage of the 65,536 random PAM sequences.
High-throughput sequencing
Library DNA was harvested by spin columns (Qiagen, Carlsbad CA) after 12 hours of
antibiotic selection. Intact PAMs were amplified with barcoded primers (Supplementary
Data) and sequences obtained from overlapping 25bp paired-end reads on an Illumina
MiSeq. MiSeq yielded 18,411,704 total reads or 9,205,852 paired-end reads with an average
quality score >34 for each library. Paired end reads were merged and filtered for perfect
alignment to each other, their protospacer, and the plasmid backbone. The remaining
7,652,454 merged filtered reads were trimmed to remove plasmid backbone and protospacer
sequences and then used to generate position weight matrices for each PAM library. Each
library combination received at least 450,000 high-quality reads.
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To calculate the fold depletion for each candidate PAM, we employed two scripts to filter
the data (Supplementary Data). patternProp (usage: python patternProp.py [PAM] file.fastq)
returns the number and fraction of reads matching each 1-base derivative of the indicated
PAM. 1-base derivatives are defined as the set of all sequences in which one additional base
that was not specified in the parent (i.e. N) is set to A, C, G, or T. patternProp3 returns the
fraction of reads matching each 1-base derivative relative to the total number of reads for the
library. Spreadsheets detailing depletion ratios for each calculated PAM were used to
identify the minimal fold depletion among all 1-base derivatives and thereby classify PAMs
(Supplementary Data).
Repression and orthogonality assays in bacteria
Cas9-mediated repression was assayed by transforming the NM expression plasmid and the
YFP reporter plasmid with each of the two corresponding targeting plasmids. Colonies with
matching or mismatched spacer and protospacer were picked and grown in 96-well plates.
Fluorescence at 495–528 nm and absorbance at 600nm were measured using a Synergy Neo
microplate reader (BioTek, Winooski VT).
Orthogonality tests were performed by preparing electrocompetent NEBTurbo cells bearing
all combinations of Cas9 and targeting plasmids and transforming them with matched or
mismatched substrate plasmids bearing appropriate PAMs for each Cas9. Sufficient cells
and dilutions were plated to ensure that at least some colonies appeared even for correct
Cas9 + targeting + matching protospacer combinations, which typically arise due to
mutational inactivation of the Cas9 or the crRNA. Colonies were counted and fold depletion
calculated for each.
For the simultaneous nuclease and repression assays, cells were first rendered
electrocompetent, transformed with the SP phage defense plasmid, and plated with
erythromycin, kanamycin, chloramphenicol, and spectinomycin. Plaque assays were
performed by mixing dilutions of M13mp18 phage (New England Biolabs, Ipswich, MA)
with 75 uL cells (NEBTurbo, containing the F plasmid), combining with 1 mL soft agar, and
plating onto 60 mm LB plates with 50 μ g/mL IPTG and 200 μ g/mL X-Gal. For the plasmid
transformation assay, cells were rendered electrocompetent by standard methods,
transformed with plasmids bearing wild-type or recoded gene III, and plated with
carbenicillin, erythromycin, kanamycin, chloramphenicol, and spectinomycin. Plaque assays
were imaged using a Typhoon FLA 9000 (GE, Fairfield, CT), and the contrast adjusted by
setting the maximum saturation to 1.0% using ImageJ.
Cell culture and transfections
HEK 293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen) high glucose supplemented with 10% fetal bovine serum (FBS, Invitrogen),
penicillin/streptomycin (pen/strep, Invitrogen), and non-essential amino acids (NEAA,
Invitrogen). Cells were maintained at 37°C and 5% CO2 in a humidified incubator.
Transfections involving nuclease assays were as follows: 0.4×106cells were transfected with
2μ g Cas9 plasmid, 2μ g gRNA and/or 2μ g DNA donor plasmid using Lipofectamine 2000 as
per the manufacturer’s protocols. Cells were harvested 3 days after transfection and either
analyzed by FACS, or for direct assay of genomic cuts the genomic DNA of ~1 × 106 cells
was extracted using DNAeasy kit (Qiagen).
For transfections involving transcriptional activation assays: 0.4×106cells were transfected
with 2μ g Cas9N-VP64 plasmid, 2μ g gRNA and/or 0.25μ g of reporter construct. Cells were
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tharvested 24–48hrs post transfection and assayed using FACS or immunofluorescence
methods, or their total RNA was extracted and these were subsequently analyzed by RT-
PCR.
Statistical Analyses
No samples were excluded from any experiments.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Comparison and characterization of putatively orthogonal Cas9 proteins. (a) Repeat
sequences of SP, ST1, NM, and TD. Bases are colored to indicate the degree of
conservation. (b) Plasmids used for characterization of Cas9 proteins in E. coli. All carry
compatible replication origins and antibiotic resistance genes. (c) Selection scheme to
identify PAMs. Cells expressing a Cas9 protein and one of two spacer-containing targeting
plasmids were transformed with one of two PAM libraries with corresponding protospacers
and subjected to antibiotic selection. Surviving uncleaved plasmids were subjected to deep
sequencing. Cas9-mediated PAM depletion was quantified by comparing the relative
abundance of each sequence within the matched versus the mismatched protospacer
libraries. (d) Functional PAMs are depleted from the library by Cas9 when the targeting
Esvelt et al. Page 11
Nat Methods. Author manuscript; available in PMC 2014 May 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tplasmid spacer matches the library plasmid protospacer. (e) Cas9 does not cut when the
spacer and protospacer do not match. (f) Nonfunctional PAMs are never cut or depleted.
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tFig. 2.
Depletion of functional protospacer-adjacent motifs (PAMs) from libraries by Cas9 proteins.
The log frequency of each base at every position for matched spacer-protospacer pairs is
plotted relative to control conditions in which spacer and protospacer did not match. Results
reflect the mean depletion of libraries by NM (a), ST1 (b), and TD (c) based on two distinct
protospacer sequences (d). Depletion of specific sequences for each protospacer are plotted
separately for each Cas9 protein (d–f).
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tFig. 3.
Orthogonal recognition of crRNAs in E. coli. Cells with all 16 combinations of Cas9 and
crRNA were challenged with a plasmid bearing a matched or mismatched protospacer and
appropriate PAM. Sufficient cells were plated to reliably obtain colonies from matching
spacer and protospacer pairings. Total colony counts on the resulting 32 plates were used to
calculate the fold depletion. Values less than one were set to one for clarity.
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tFig. 4.
Transcriptional repression simultaneous with nuclease activity in bacteria. (a) Reporter
plasmids for quantification of Cas9 repression contained protospacer B and a suitable PAM
in the non-template strand after the YFP start codon. Normalized cellular fluorescence is
shown for mismatched and matched spacer-protospacer pairs. PAMs for each Cas9 are
shown. (b) Cas9 ortholog repression was verified with a second reporter plasmid containing
protospacer A and a PAM in the non-template strand within the 5′  UTR. Error bars represent
the standard deviation of eight independently picked cultures for all repression experiments.
(c) Cells containing the plasmids used for NM-mediated repression (Fig. 3a) were
transformed with a compatible plasmid encoding SP, its tracrRNA, and a 5-spacer CRISPR
locus designed to cleave filamentous phage gene III at multiple sites and challenged with
M13mp18. The phage defense plasmid completely prevented plaque formation while
preserving YFP repression. (d) Cells were transformed with a compatible plasmid encoding
carbenicillin resistance and either wild-type gene III or a recoded version lacking
protospacers and plated. Plasmids encoding wild-type gene III were perfectly excluded from
cells encoding the SP phage defense, which did not interfere with YFP repression. Scale
bars, 10 mm.
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tFig. 5.
Cas9-mediated gene editing in human cells. (a) A homologous recombination assay was
used to quantify gene editing efficiency. Cas9-mediated double-strand breaks within the
protospacer stimulated repair of the interrupted GFP cassette using the donor template,
yielding cells with intact GFP. Three different templates were used in order to provide the
correct PAM for each Cas9. Fluorescent cells were quantified by flow cytometry. (b)
Homologous recombination efficiencies for NM, ST1, and TD in combination with each of
their respective sgRNAs. Substrate PAMs are displayed below each Cas9. Data represent
mean values ± s.e.m. (n=3).
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tFig. 6.
Transcriptional activation in human cells. (a) Reporter constructs for transcriptional
activation featured a minimal promoter driving tdTomato. Nuclease-null Cas9-VP64 fusion
proteins binding to upstream protospacers resulted in transcriptional activation and enhanced
fluorescence. (b) Cells were transfected with all combinations of Cas9 activators and
sgRNAs and tdTomato fluorescence visualized by microscopy. Transcriptional activation
occurred only when each Cas9 was paired with its own sgRNA. Scale bars, 100 μ m. (c)
Activation was quantified by flow cytometry along with a TAL-VP64 effector targeting an
upstream sequence for comparison. Data represent mean values ± s.e.m. (n=3).
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